News

Bronchial thermoplasty gains momentum for severe asthma


 

EXPERT ANALYSIS FROM THE 2015 AAAAI ANNUAL MEETING

References

An estimated 5% of asthma patients are categorized as having severe disease. Bronchial thermoplasty has been approved by the FDA for the treatment of severe asthma since 2010. The outpatient procedure entails delivery of radiofrequency energy to the lungs in three sessions spaced several weeks apart.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

Headache • fatigue • blurred vision • Dx?
MDedge Family Medicine
Anxiety tied to fear of falling • fatigue • difficulty concentrating • Dx?
MDedge Family Medicine
Executive function deficits linked to e-cigarette use in early adolescents
MDedge Family Medicine
Sitting while watching television tied to poor sleep, obstructive sleep apnea risk
MDedge Family Medicine
U.S. grants drug company $12 million to develop Ebola drug
MDedge Family Medicine
Beta-lactam monotherapy effective for suspected community-acquired pneumonia
MDedge Family Medicine
No increased risk of lung disease with methotrexate
MDedge Family Medicine
Avoid voriconazole in transplant patients at risk for skin cancer
MDedge Family Medicine
Early pneumonia linked with later asthma and COPD
MDedge Family Medicine
‘Mossy Oak sign’ suggests delayed anaphylaxis to red meat
MDedge Family Medicine